Acceptability of the COVID-19 vaccine among patients with chronic rheumatic diseases and health-care professionals: a cross-sectional study in 19 Arab countries

Affiliations

• ¹ Division of Rheumatology, Specialized Medical Center, Riyadh, Saudi Arabia.
• ² Department of Internal Medicine, Specialized Medical Center, Riyadh, Saudi Arabia.
• ³ Rheumatology Unit, Temara Hospital, Laboratory of Biostatistics, Clinical Research and Epidemiology, Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
• ⁴ Rheumatology Unit, Department of Medicine, College of Medicine, University of Baghdad, Baghdad, Iraq.
• ⁵ Rheumatology Department, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.
• ⁶ Rheumatology Department, Cairo University, Cairo, Egypt.
• ⁷ Rheumatology Department, Douera Hospital, Faculty of Medicine, Saad Dahlab, Blida, Algeria.
• ⁸ Rheumatology Division, Internal Medicine Department, Jordan Hospital, Amman, Jordan.
• ⁹ Rheumatology Unit, Department of Medicine, Jaber Alahmed Alsabah Hospital, Kuwait City, Kuwait.
• ¹⁰ Rheumatology Department, Kassab Institute of Orthopedics, UR17SP04, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis, Tunisia.
• ¹¹ Medicine Department, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon.
• ¹² Rheumatology Department, Centre National de Référence des Maladies Auto-immunes Systémiques Rares Est Sud-Ouest RESO, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
• ¹³ Rheumatology Department, Saint-Joseph University and Hotel-Dieu de France Hospital, Beirut 1100, Lebanon.